Vimarsana
Biggest News Aggregation in the World

Page 2 - Advanced Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advanced Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advanced Lab Today - Breaking & Trending Today

Palatin starts mid-stage study of bremelanotide for diabetic kidney disease - Vimarsana News

Palatin starts mid-stage study of bremelanotide for diabetic kidney disease

Palatin Technologies (PTN) said it started enrollment in a phase 2b trial of bremelanotide to treat diabetic kidney disease.The company added that patient screening/enrollment had begun...

Galecto stock rises 12% as GB1211 shows efficacy in liver disease patients in trial - Vimarsana News

Galecto stock rises 12% as GB1211 shows efficacy in liver disease patients in trial

Galecto (GLTO) said its medicine GB1211 helped reduce certain liver enzymes in patients with decompensated cirrhosis in a phase 1b/2a trial.The study, dubbed GULLIVER-2, evaluated...

Relief reports stability data on new formulation of lung disease drug RLF-100 - Vimarsana News

Relief reports stability data on new formulation of lung disease drug RLF-100

Relief Therapeutics (RLFTF)(RLFTD) reported six-month stability data on a new formulation of potential lung disease therapy RLF-100 (aviptadil).The company said the data showed high...

IPO Update: Acrivon Therapeutics Readies $100 Million IPO - Vimarsana News

IPO Update: Acrivon Therapeutics Readies $100 Million IPO

Acrivon Therapeutics has filed proposed terms for a $100 million U.S. IPO. Click here to read more about ACRV stock and about the IPO.

Affimed stock soars 22% on team up with Artiva to develop combo cell therapy - Vimarsana News

Affimed stock soars 22% on team up with Artiva to develop combo cell therapy

Germany's Affimed (AFMD) and San Diego-based Artiva Biotherapeutics signed an agreement to jointly develop and commercialize a combination therapy to treat cancer.The combo...